PinnedPablo LubrothTechBio KPIs: Is Your Discovery Platform Validated?Pablo Lubroth is an investor at Hummingbird Ventures, a global early stage fund, where he covers bio + health. Viswa Colluru is the Founder…11 min read·Apr 5, 2022----
PinnedPablo LubrothDefensibility Through Execution: Building the Next Generation of Bio PlatformsPablo Lubroth and Xinchen Wang7 min read·Feb 14, 2022----
Pablo LubrothIn vivo Genome Editing Therapeutic Approaches for Neurological Disorders: Where Are We in the…By Pablo Lubroth, Gaia Colasante and Gabriele Lignani1 min read·Feb 25, 2021----
Pablo LubrothCan We Predict Drug Efficacy with Artificial Intelligence?By Jeanne-Françoise Williamson D.Phil, CEO, Williamson Biotech Solutions and Pablo Lubroth, University of Cambridge, MPhil Bioscience…4 min read·Oct 17, 2017----
Pablo LubrothLondon Psychotropics: Restrictions on Classified Drugs, A Research PerspectiveLondon Psychotropics is a novel group for neuroscientists of all levels and career backgrounds interested in drugs and the brain. The…3 min read·Feb 16, 2016----